Financials data is unavailable for this security.
View more
Year on year Plus Therapeutics Inc grew revenues 2,093.30% from 224.00k to 4.91m while net income improved from a loss of 20.28m to a smaller loss of 13.32m.
Gross margin | -- |
---|---|
Net profit margin | -240.15% |
Operating margin | -256.07% |
Return on assets | -104.14% |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Plus Therapeutics Inc fell by 9.57m. Cash Flow from Financing totalled 3.45m or 70.12% of revenues. In addition the company used 12.85m for operations while cash used for investing totalled 160.00k.
Cash flow per share | -2.72 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -1.34 |
---|---|
Tangible book value per share | -1.50 |
More ▼
Balance sheet in USDView more
Current ratio | 0.4993 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼